Suppr超能文献

维地昔诺(KPT-335),一种选择性核输出抑制剂,可降低呼吸道合胞病毒的复制。

Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication .

机构信息

Animal Health Research Center, Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA.

Respiratory Virology Group, Centre for Research in Therapeutic Solutions, Faculty of Science and Technology, University of Canberra, Canberra, Australia.

出版信息

J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01684-18. Print 2019 Feb 15.

Abstract

Respiratory syncytial virus (RSV) is a leading cause of hospitalization of infants and young children, causing considerable respiratory disease and repeat infections that may lead to chronic respiratory conditions such as asthma, wheezing, and bronchitis. RSV causes ∼34 million new episodes of lower respiratory tract illness (LRTI) in children younger than 5 years of age, with >3 million hospitalizations due to severe RSV-associated LRTI. The standard of care is limited to symptomatic relief as there are no approved vaccines and few effective antiviral drugs; thus, a safe and efficacious RSV therapeutic is needed. Therapeutic targeting of host proteins hijacked by RSV to facilitate replication is a promising antiviral strategy as targeting the host reduces the likelihood of developing drug resistance. The nuclear export of the RSV M protein, mediated by the nuclear export protein exportin 1 (XPO1), is crucial for RSV assembly and budding. Inhibition of RSV M protein export by leptomycin B correlated with reduced RSV replication In this study, we evaluated the anti-RSV efficacy of Verdinexor (KPT-335), a small molecule designed to reversibly inhibit XPO1-mediated nuclear export. KPT-335 inhibited XPO1-mediated transport and reduced RSV replication KPT-335 was effective against RSV A and B strains and reduced viral replication following prophylactic or therapeutic administration. Inhibition of RSV replication by KPT-335 was due to a combined effect of reduced XPO1 expression, disruption of the nuclear export of RSV M protein, and inactivation of the NF-κB signaling pathway. RSV is an important cause of LRTI in infants and young children for which there are no suitable antiviral drugs offered. We evaluated the efficacy of KPT-335 as an anti-RSV drug and show that KPT-335 inhibits XPO1-mediated nuclear export, leading to nuclear accumulation of RSV M protein and reduction in RSV levels. KPT-335 treatment also resulted in inhibition of proinflammatory pathways, which has important implications for its effectiveness .

摘要

呼吸道合胞病毒(RSV)是导致婴儿和幼儿住院的主要原因,会引起严重的呼吸道疾病,并导致反复感染,从而可能导致哮喘、喘息和支气管炎等慢性呼吸道疾病。RSV 导致 5 岁以下儿童发生约 3400 万例新的下呼吸道疾病(LRTI),其中因严重 RSV 相关 LRTI 导致 300 多万人住院。由于没有批准的疫苗和很少有效的抗病毒药物,因此目前的治疗标准仅限于对症缓解,因此需要一种安全有效的 RSV 治疗药物。针对 RSV 劫持宿主蛋白以促进复制的治疗方法是一种很有前途的抗病毒策略,因为针对宿主可以降低产生耐药性的可能性。RSV M 蛋白的核输出由核输出蛋白 exportin 1(XPO1)介导,这对于 RSV 的组装和出芽至关重要。莱普霉素 B 抑制 RSV M 蛋白的输出与 RSV 复制减少相关。在这项研究中,我们评估了 Verdinexor(KPT-335)的抗 RSV 疗效,Verdinexor 是一种设计用于可逆抑制 XPO1 介导的核输出的小分子。KPT-335 抑制 XPO1 介导的运输并减少 RSV 复制。KPT-335 对 RSV A 和 B 株有效,并在预防性或治疗性给药后减少病毒复制。KPT-335 通过减少 XPO1 表达、破坏 RSV M 蛋白的核输出以及失活 NF-κB 信号通路来抑制 RSV 复制。RSV 是导致婴儿和幼儿 LRTI 的重要原因,但目前尚无有效的抗病毒药物。我们评估了 KPT-335 作为抗 RSV 药物的疗效,并表明 KPT-335 抑制 XPO1 介导的核输出,导致 RSV M 蛋白在核内积累并减少 RSV 水平。KPT-335 治疗还导致促炎途径的抑制,这对其有效性具有重要意义。

相似文献

2
Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.
J Virol. 2014 Sep 1;88(17):10228-43. doi: 10.1128/JVI.01774-14. Epub 2014 Jun 25.
5
KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma.
Cancer Chemother Pharmacol. 2014 Sep;74(3):487-95. doi: 10.1007/s00280-014-2495-8. Epub 2014 Jul 17.
9
The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism.
J Virol. 2009 Jun;83(11):5353-62. doi: 10.1128/JVI.02374-08. Epub 2009 Mar 18.
10
Selective Inhibitor of Nuclear Export (SINE) Compounds Alter New World Alphavirus Capsid Localization and Reduce Viral Replication in Mammalian Cells.
PLoS Negl Trop Dis. 2016 Nov 30;10(11):e0005122. doi: 10.1371/journal.pntd.0005122. eCollection 2016 Nov.

引用本文的文献

1
Advances in development of antiviral strategies against respiratory syncytial virus.
Acta Pharm Sin B. 2025 Apr;15(4):1752-1772. doi: 10.1016/j.apsb.2025.02.015. Epub 2025 Feb 20.
2
Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue.
MedComm (2020). 2024 Nov 21;5(12):e70016. doi: 10.1002/mco2.70016. eCollection 2024 Dec.
3
4
Beyond oncology: Selinexor's journey into anti-inflammatory treatment and long-term management.
Front Immunol. 2024 May 10;15:1398927. doi: 10.3389/fimmu.2024.1398927. eCollection 2024.
5
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus.
Molecules. 2024 Jan 25;29(3):598. doi: 10.3390/molecules29030598.
8
Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitors.
Front Immunol. 2023 Oct 26;14:1275329. doi: 10.3389/fimmu.2023.1275329. eCollection 2023.

本文引用的文献

2
ICTV Virus Taxonomy Profile: Pneumoviridae.
J Gen Virol. 2017 Dec;98(12):2912-2913. doi: 10.1099/jgv.0.000959. Epub 2017 Oct 31.
3
CRM1 Inhibitors for Antiviral Therapy.
Front Microbiol. 2017 Jun 28;8:1171. doi: 10.3389/fmicb.2017.01171. eCollection 2017.
4
Respiratory syncytial virus: prospects for new and emerging therapeutics.
Expert Rev Respir Med. 2017 Aug;11(8):609-615. doi: 10.1080/17476348.2017.1338567. Epub 2017 Jun 14.
5
Selective Inhibitor of Nuclear Export (SINE) Compounds Alter New World Alphavirus Capsid Localization and Reduce Viral Replication in Mammalian Cells.
PLoS Negl Trop Dis. 2016 Nov 30;10(11):e0005122. doi: 10.1371/journal.pntd.0005122. eCollection 2016 Nov.
6
Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection.
PLoS One. 2016 Nov 28;11(11):e0167221. doi: 10.1371/journal.pone.0167221. eCollection 2016.
7
Rhinovirus 16 2A Protease Affects Nuclear Localization of 3CD during Infection.
J Virol. 2016 Nov 28;90(24):11032-11042. doi: 10.1128/JVI.00974-16. Print 2016 Dec 15.
9
Quantification of RSV Infectious Particles by Plaque Assay and Immunostaining Assay.
Methods Mol Biol. 2016;1442:33-40. doi: 10.1007/978-1-4939-3687-8_3.
10
The Regulation of NF-κB Subunits by Phosphorylation.
Cells. 2016 Mar 18;5(1):12. doi: 10.3390/cells5010012.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验